Arthritis and CBD — The Current Evidence
There are two main types of arthritis relevant to CBD research: osteoarthritis (OA, the degenerative “wear and tear” type) and rheumatoid arthritis (RA, the autoimmune type). The mechanisms by which CBD might help differ significantly between them.
Osteoarthritis
OA pain is largely inflammatory and nociceptive. CBD’s anti-inflammatory properties — primarily through TRPV1 channel modulation and inhibition of inflammatory cytokines — make it mechanistically plausible. A 2020 pilot study found topical CBD gel reduced OA pain by 47% compared to placebo. Oral CBD studies are ongoing.
Rheumatoid Arthritis
RA’s autoimmune component means treatment is more complex. However, CBD’s immunomodulatory effects are of significant interest. Animal models consistently show CBD reduces autoimmune-driven joint damage. Human evidence is limited to survey data, but reported outcomes are positive — particularly for morning stiffness and sleep quality.
Topical vs Oral CBD for Arthritis
For localised joint pain, topical CBD cream or balm allows direct application and avoids systemic absorption — useful for those on multiple medications. For widespread joint pain or systemic inflammation (as in RA), oral CBD oil provides systemic coverage. Many patients use both.
Do not stop or reduce prescribed arthritis medication without consulting your rheumatologist or GP. CBD may interact with methotrexate and other DMARDs.